ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.18
+0.46 (2.12%)
At close: May 13, 2026, 4:00 PM EDT
22.21
+0.03 (0.14%)
After-hours: May 13, 2026, 5:37 PM EDT

ACADIA Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0951,072957.8726.44517.24484.15
Revenue Growth (YoY)
9.93%11.87%31.85%40.45%6.83%9.60%
Cost of Revenue
93.48981.8441.6410.1719.14
Gross Profit
1,002982.51875.96684.8507.07465
Selling, General & Admin
593.54548.89488.43406.56369.09396.03
Research & Development
327.41328.8303.25351.62361.58239.42
Other Operating Expenses
---146.52---
Total Operating Expenses
920.95877.7645.16758.18730.67635.44
Operating Income
80.91104.81230.79-73.38-223.6-170.44
Interest Income
31.8831.7225.4617.236.610.59
Other Non-Operating Income (Expense)
2.332.371.825.113.542.33
Total Non-Operating Income (Expense)
34.234.0927.2822.3410.152.92
Pretax Income
115.11138.9258.08-51.04-213.44-167.52
Provision for Income Taxes
-260.54-252.131.6210.252.530.35
Net Income
375.65391226.45-61.29-215.98-167.87
Net Income to Common
375.65391226.45-61.29-215.98-167.87
Net Income Growth
64.12%72.66%----
Shares Outstanding (Basic)
169168166164162160
Shares Outstanding (Diluted)
171170166164162160
Shares Change (YoY)
2.50%2.14%1.55%1.32%0.74%2.01%
EPS (Basic)
2.232.321.37-0.37-1.34-1.05
EPS (Diluted)
2.202.301.36-0.37-1.34-1.05
EPS Growth
60.58%69.12%----
Shares Outstanding
171.09170.31166.71164.65162.07161.01
Free Cash Flow
113.59105.15157.216.65-114.04-126.78
Free Cash Flow Growth
8.03%-33.11%844.01%---
Free Cash Flow Per Share
0.660.620.940.10-0.71-0.79
Gross Margin
91.47%91.69%91.46%94.27%98.03%96.05%
Operating Margin
7.39%9.78%24.10%-10.10%-43.23%-35.20%
Profit Margin
34.30%36.49%23.64%-8.44%-41.76%-34.67%
FCF Margin
10.37%9.81%16.41%2.29%-22.05%-26.19%
EBITDA
92.71116.57246.68-67.83-223.6-167.1
EBITDA Margin
8.46%10.88%25.75%-9.34%-43.23%-34.51%
EBIT
80.91104.81230.79-73.38-223.6-170.44
EBIT Margin
7.39%9.78%24.10%-10.10%-43.23%-35.20%
Effective Tax Rate
-226.35%-181.49%12.25%-20.08%-1.19%-0.21%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q